Celldex’s anti-KIT antibody meets endpoints in two Phase III CSU trials
Before the CSU win, Celldex recently terminated the anti-KIT antibody’s separate development in PN.
The post Celldex’s anti-KIT antibody meets endpoints in two Phase III CSU trials appeared first on Clinical Trials Arena .